Theralase Technologies Inc. announced that it has appointed Michael Borovec as the director of investor relations for the company. Michael possesses over 10 years' experience in investor relations and capital markets. He successfully completed the Canadian Securities Course, as well as his Series 7, 22 and 63 US licences in 2001.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 CAD | +3.12% | +6.45% | -5.71% |
Apr. 24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
Apr. 05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.71% | 28.03M | |
+6.15% | 860M | |
-25.86% | 236M | |
-38.71% | 71.43M | |
+26.41% | 61.08M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Inc. Announces Appointment of Michael Borovec as Director of Investor Relations